Characterization of Gcf2/Lrrfip1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and β-catenin signaling pathways

Neuroscience

Volumn 268, Issue , 2014, Pages 48-65

  Gubern, C ^a   Camos S ^a   Hurtado, O ^b   Rodriguez R ^a   Romera, V G ^b   Sobrado, M ^b   Canadas R ^b   Moro, M A ^b   Lizasoain, I ^b   Serena, J ^a   Mallolas, J ^a   Castellanos, M ^a  

^a GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Astrocytes; GLT 1; Lrrfip1; MCAO; OGD; Stroke

Indexed keywords

BETA CATENIN; EXCITATORY AMINO ACID TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER SUBTYPE 2; ISOPROTEIN; LEUCINE RICH REPEAT IN FLIGHTLESS 1 INTERACTION PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; CTNNB1 PROTEIN, RAT; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; LRRFIP1 PROTEIN, RAT; MTOR PROTEIN, RAT; RNA BINDING PROTEIN; RNA ISOFORM; SLC1A2 PROTEIN, RAT; TARGET OF RAPAMYCIN KINASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; LEUCINE RICH REPEAT IN FLIGHTLESS 1 INTERACTION PROTEIN 1 GENE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REGULATOR GENE; UPREGULATION; ANIMAL; ASTROCYTE; BRAIN; CELL CULTURE; CEREBRAL ARTERY DISEASE; COMPLICATION; CYTOPLASM; FISCHER 344 RAT; GENE SILENCING; GENETICS; METABOLISM; NERVE CELL; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; ASTROCYTES; BETA CATENIN; BRAIN; BRAIN ISCHEMIA; CELLS, CULTURED; CYTOPLASM; EXCITATORY AMINO ACID TRANSPORTER 2; GENE KNOCKDOWN TECHNIQUES; GLUTAMIC ACID; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEURONS; PROTO-ONCOGENE PROTEINS C-AKT; RATS, INBRED F344; RATS, WISTAR; RNA ISOFORMS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; UP-REGULATION;

EID: 84897416928     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.02.051     Document Type: Article

References (70)

1. Arakawa R., Bagashev A., Song L., Maurer K., Sullivan K.E. Characterization of LRRFIP1. Biochem Cell Biol 2010, 88:899-906.
2. Ariake K., Ohtsuka H., Motoi F., Douchi D., Oikawa M., Rikiyama T., Fukase K., Katayose Y., Egawa S., Unno M. GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-dependent RhoA activation. Cancer Lett 2012, 325:99-107.
3. Bagashev A., Fitzgerald M.C., Larosa D.F., Rose P.P., Cherry S., Johnson A.C., Sullivan K.E. Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response. J Interferon Cytokine Res 2010, 30:843-852.
4. Brembeck F.H., Rosario M., Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 2006, 16:51-59.
5. Buga A.M., Sascau M., Pisoschi C., Herndon J.G., Kessler C., Popa-Wagner A. The genomic response of the ipsilateral and contralateral cortex to stroke in aged rats. J Cell Mol Med 2008, 12:2731-2753.
6. Buga A.M., Scholz C.J., Kumar S., Herndon J.G., Alexandru D., Cojocaru G.R., Dandekar T., Popa-Wagner A. Identification of new therapeutic targets by genome-wide analysis of gene expression in the ipsilateral cortex of aged rats after stroke. PLoS One 2012, 7:e50985.
7. Campbell H.D., Fountain S., McLennan I.S., Berven L.A., Crouch M.F., Davy D.A., Hooper J.A., Waterford K., Chen K.S., Lupski J.R., Ledermann B., Young I.G., Matthaei K.I. Fliih, a gelsolin-related cytoskeletal regulator essential for early mammalian embryonic development. Mol Cell Biol 2002, 22:3518-3526.
8. Caso J.R., Pradillo J.M., Hurtado O., Lorenzo P., Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007, 115:1599-1608.
9. Choi D.W., Rothman S.M. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990, 13:171-182.
10. Chong Z.Z., Shang Y.C., Wang S., Maiese K. A critical kinase cascade in neurological disorders: PI3-K, Akt, and mTOR. Future Neurol 2012, 7:733-748.
11. Chong Z.Z., Shang Y.C., Zhang L., Wang S., Maiese K. Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxid Med Cell Longev 2010, 3:374-391.
12. Dai P., Jeong S.Y., Yu Y., Leng T., Wu W., Xie L., Chen X. Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J Immunol 2009, 182:3450-3460.
13. Danbolt N.C. Glutamate uptake. Prog Neurobiol 2001, 65:1-105.
14. Dirnagl U., Iadecola C., Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999, 22:391-397.
15. Eden S., Constancia M., Hashimshony T., Dean W., Goldstein B., Johnson A.C., Keshet I., Reik W., Cedar H. An upstream repressor element plays a role in Igf2 imprinting. EMBO J 2001, 20:3518-3525.
16. Etienne-Manneville S., Hall A. Rho GTPases in cell biology. Nature 2002, 420:629-635.
17. Fang D., Hawke D., Zheng Y., Xia Y., Meisenhelder J., Nika H., Mills G.B., Kobayashi R., Hunter T., Lu Z. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. J Biol Chem 2007, 282:11221-11229.
18. Flicek P., Amode M.R., Barrell D., Beal K., Brent S., Carvalho-Silva D., Clapham P., Coates G., Fairley S., Fitzgerald S., Gil L., Gordon L., Hendrix M., Hourlier T., Johnson N., Kahari A.K., Keefe D., Keenan S., Kinsella R., Komorowska M., Koscielny G., Kulesha E., Larsson P., Longden I., McLaren W., Muffato M., Overduin B., Pignatelli M., Pritchard B., Riat H.S., Ritchie G.R., Ruffier M., Schuster M., Sobral D., Tang Y.A., Taylor K., Trevanion S., Vandrovcova J., White S., Wilson M., Wilder S.P., Aken B.L., Birney E., Cunningham F., Dunham I., Durbin R., Fernandez-Suarez X.M., Harrow J., Herrero J., Hubbard T.J., Parker A., Proctor G., Spudich G., Vogel J., Yates A., Zadissa A., Searle S.M. Ensembl 2012. Nucleic Acids Res 2012, 40:D84-D90.
19. Florian B., Vintilescu R., Balseanu A.T., Buga A.M., Grisk O., Walker L.C., Kessler C., Popa-Wagner A. Long-term hypothermia reduces infarct volume in aged rats after focal ischemia. Neurosci Lett 2008, 438:180-185.
20. Fong K.S., de Couet H.G. Novel proteins interacting with the leucine-rich repeat domain of human flightless-I identified by the yeast two-hybrid system. Genomics 1999, 58:146-157.
21. Gegelashvili G., Robinson M.B., Trotti D., Rauen T. Regulation of glutamate transporters in health and disease. Prog Brain Res 2001, 132:267-286.
22. Goodall A.H., Burns P., Salles I., Macaulay I.C., Jones C.I., Ardissino D., de Bono B., Bray S.L., Deckmyn H., Dudbridge F., Fitzgerald D.J., Garner S.F., Gusnanto A., Koch K., Langford C., O'Connor M.N., Rice C.M., Stemple D., Stephens J., Trip M.D., Zwaginga J.J., Samani N.J., Watkins N.A., Maguire P.B., Ouwehand W.H. Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function. Blood 2010, 116:4646-4656.
23. Gubern C., Camos S., Ballesteros I., Rodriguez R., Romera V.G., Canadas R., Lizasoain I., Moro M.A., Serena J., Mallolas J., Castellanos M. miRNA expression is modulated over time after focal ischaemia: up-regulation of miR-347 promotes neuronal apoptosis. FEBS J 2013, 280:6233-6246.
24. Gubern C., Hurtado O., Rodriguez R., Morales J.R., Romera V.G., Moro M.A., Lizasoain I., Serena J., Mallolas J. Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia. BMC Mol Biol 2009, 10:57.
25. Hahn-Windgassen A., Nogueira V., Chen C.C., Skeen J.E., Sonenberg N., Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005, 280:32081-32089.
26. Hanke M.L., Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) 2011, 121:367-387.
27. Hua F., Ma J., Ha T., Kelley J.L., Kao R.L., Schweitzer J.B., Kalbfleisch J.H., Williams D.L., Li C. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice. Brain Res 2009, 1262:100-108.
28. Hurtado O., Moro M.A., Cardenas A., Sanchez V., Fernandez-Tome P., Leza J.C., Lorenzo P., Secades J.J., Lozano R., Davalos A., Castillo J., Lizasoain I. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport. Neurobiol Dis 2005, 18:336-345.
29. Jiang W., Zhang S., Fu F., Zhu H., Hou J. Inhibition of nuclear factor-kappaB by 6-O-acetyl shanzhiside methyl ester protects brain against injury in a rat model of ischemia and reperfusion. J Neuroinflammation 2010, 7:55.
30. Joseph C., Buga A.M., Vintilescu R., Balseanu A.T., Moldovan M., Junker H., Walker L., Lotze M., Popa-Wagner A. Prolonged gaseous hypothermia prevents the upregulation of phagocytosis-specific protein annexin 1 and causes low-amplitude EEG activity in the aged rat brain after cerebral ischemia. J Cereb Blood Flow Metab 2012, 32:1632-1642.
31. Khachigian L.M., Santiago F.S., Rafty L.A., Chan O.L., Delbridge G.J., Bobik A., Collins T., Johnson A.C. GC factor 2 represses platelet-derived growth factor A-chain gene transcription and is itself induced by arterial injury. Circ Res 1999, 84:1258-1267.
32. Kopecki Z., Arkell R., Powell B.C., Cowin A.J. Flightless I regulates hemidesmosome formation and integrin-mediated cellular adhesion and migration during wound repair. J Invest Dermatol 2009, 129:2031-2045.
33. Lee Y.H., Stallcup M.R. Interplay of Fli-I and FLAP1 for regulation of beta-catenin dependent transcription. Nucleic Acids Res 2006, 34:5052-5059.
34. Lei Z.N., Zhang L.M., Sun F.Y. Beta-catenin siRNA inhibits ischemia-induced striatal neurogenesis in adult rat brain following a transient middle cerebral artery occlusion. Neurosci Lett 2008, 435:108-112.
35. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., Bernard A., Boe A.F., Boguski M.S., Brockway K.S., Byrnes E.J., Chen L., Chen T.M., Chin M.C., Chong J., Crook B.E., Czaplinska A., Dang C.N., Datta S., Dee N.R., Desaki A.L., Desta T., Diep E., Dolbeare T.A., Donelan M.J., Dong H.W., Dougherty J.G., Duncan B.J., Ebbert A.J., Eichele G., Estin L.K., Faber C., Facer B.A., Fields R., Fischer S.R., Fliss T.P., Frensley C., Gates S.N., Glattfelder K.J., Halverson K.R., Hart M.R., Hohmann J.G., Howell M.P., Jeung D.P., Johnson R.A., Karr P.T., Kawal R., Kidney J.M., Knapik R.H., Kuan C.L., Lake J.H., Laramee A.R., Larsen K.D., Lau C., Lemon T.A., Liang A.J., Liu Y., Luong L.T., Michaels J., Morgan J.J., Morgan R.J., Mortrud M.T., Mosqueda N.F., Ng L.L., Ng R., Orta G.J., Overly C.C., Pak T.H., Parry S.E., Pathak S.D., Pearson O.C., Puchalski R.B., Riley Z.L., Rockett H.R., Rowland S.A., Royall J.J., Ruiz M.J., Sarno N.R., Schaffnit K., Shapovalova N.V., Sivisay T., Slaughterbeck C.R., Smith S.C., Smith K.A., Smith B.I., Sodt A.J., Stewart N.N., Stumpf K.R., Sunkin S.M., Sutram M., Tam A., Teemer C.D., Thaller C., Thompson C.L., Varnam L.R., Visel A., Whitlock R.M., Wohnoutka P.E., Wolkey C.K., Wong V.Y., Wood M., Yaylaoglu M.B., Young R.C., Youngstrom B.L., Yuan X.F., Zhang B., Zwingman T.A., Jones A.R. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
36. Li S., Mallory M., Alford M., Tanaka S., Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 1997, 56:901-911.
37. Lin C.L., Bristol L.A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J.D. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998, 20:589-602.
38. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994, 330:613-622.
39. Liu Y.T., Yin H.L. Identification of the binding partners for flightless I, A novel protein bridging the leucine-rich repeat and the gelsolin superfamilies. J Biol Chem 1998, 273:7920-7927.
40. Majoul I., Shirao T., Sekino Y., Duden R. Many faces of drebrin: from building dendritic spines and stabilizing gap junctions to shaping neurite-like cell processes. Histochem Cell Biol 2007, 127:355-361.
41. Mallolas J., Hurtado O., Castellanos M., Blanco M., Sobrino T., Serena J., Vivancos J., Castillo J., Lizasoain I., Moro M.A., Davalos A. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke. J Exp Med 2006, 203:711-717.
42. Maragakis N.J., Rothstein J.D. Glutamate transporters in neurologic disease. Arch Neurol 2001, 58:365-370.
43. Marone R., Cmiljanovic V., Giese B., Wymann M.P. Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 2008, 1784:159-185.
44. Ohtsuka H., Oikawa M., Ariake K., Rikiyama T., Motoi F., Katayose Y., Unno M., Johnson A.C. GC-binding factor 2 interacts with dishevelled and regulates Wnt signaling pathways in human carcinoma cell lines. Int J Cancer 2011, 129:1599-1610.
45. Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011, 34:269-281.
46. Pereira M.P., Hurtado O., Cardenas A., Alonso-Escolano D., Bosca L., Vivancos J., Nombela F., Leza J.C., Lorenzo P., Lizasoain I., Moro M.A. The nonthiazolidinedione PPARgamma agonist L-796,449 is neuroprotective in experimental stroke. J Neuropathol Exp Neurol 2005, 64:797-805.
47. Rathinam V.A., Sharma S., Fitzgerald K.A. Catenin' on to nucleic acid sensing. Nat Immunol 2010, 11:466-468.
48. Reed A.L., Yamazaki H., Kaufman J.D., Rubinstein Y., Murphy B., Johnson A.C. Molecular cloning and characterization of a transcription regulator with homology to GC-binding factor. J Biol Chem 1998, 273:21594-21602.
49. Rikiyama T., Curtis J., Oikawa M., Zimonjic D.B., Popescu N., Murphy B.A., Wilson M.A., Johnson A.C. GCF2: expression and molecular analysis of repression. Biochim Biophys Acta 2003, 1629:15-25.
50. Robinson M.B. The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype. Neurochem Int 1998, 33:479-491.
51. Romera C., Hurtado O., Botella S.H., Lizasoain I., Cardenas A., Fernandez-Tome P., Leza J.C., Lorenzo P., Moro M.A. In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway. J Neurosci 2004, 24:1350-1357.
52. Rothman S.M., Olney J.W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 1986, 19:105-111.
53. Rozen S., Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
54. Schmelzle T., Hall M.N. TOR, a central controller of cell growth. Cell 2000, 103:253-262.
55. Seal R.P., Amara S.G. Excitatory amino acid transporters: a family in flux. Annu Rev Pharmacol Toxicol 1999, 39:431-456.
56. Shen D.W., Pouliot L.M., Gillet J.P., Ma W., Johnson A.C., Hall M.D., Gottesman M.M. The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatin. Mol Pharm 2012, 9:1822-1833.
57. Shi G.X., Andres D.A., Cai W. Ras family small GTPase-mediated neuroprotective signaling in stroke. Cent Nerv Syst Agents Med Chem 2011, 11:114-137.
58. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K., Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E. The consensus coding sequences of human breast and colorectal cancers. Science 2006, 314:268-274.
59. Sobrado M., Pereira M.P., Ballesteros I., Hurtado O., Fernandez-Lopez D., Pradillo J.M., Caso J.R., Vivancos J., Nombela F., Serena J., Lizasoain I., Moro M.A. Synthesis of lipoxin A4 by 5-lipoxygenase mediates PPARgamma-dependent, neuroprotective effects of rosiglitazone in experimental stroke. J Neurosci 2009, 29:3875-3884.
60. Suriano A.R., Sanford A.N., Kim N., Oh M., Kennedy S., Henderson M.J., Dietzmann K., Sullivan K.E. GCF2/LRRFIP1 represses tumor necrosis factor alpha expression. Mol Cell Biol 2005, 25:9073-9081.
61. Takahashi M., Billups B., Rossi D., Sarantis M., Hamann M., Attwell D. The role of glutamate transporters in glutamate homeostasis in the brain. J Exp Biol 1997, 200:401-409.
62. Tyburczy M.E., Kotulska K., Pokarowski P., Mieczkowski J., Kucharska J., Grajkowska W., Roszkowski M., Jozwiak S., Kaminska B. Novel proteins regulated by mTOR in subependymal giant cell astrocytomas of patients with tuberous sclerosis complex and new therapeutic implications. Am J Pathol 2010, 176:1878-1890.
63. Vogel C., Marcotte E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2012, 13:227-232.
64. Wilson S.A., Brown E.C., Kingsman A.J., Kingsman S.M. TRIP: a novel double stranded RNA binding protein which interacts with the leucine rich repeat of flightless I. Nucleic Acids Res 1998, 26:3460-3467.
65. Wu X., Kihara T., Akaike A., Niidome T., Sugimoto H. PI3K/Akt/mTOR signaling regulates glutamate transporter 1 in astrocytes. Biochem Biophys Res Commun 2010, 393:514-518.
66. Yang P., An H., Liu X., Wen M., Zheng Y., Rui Y., Cao X. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat Immunol 2010, 11:487-494.
67. Yuan J.S., Reed A., Chen F., Stewart C.N. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006, 7:85.
68. Yuan Y., Guo Q., Ye Z., Pingping X., Wang N., Song Z. Ischemic postconditioning protects brain from ischemia/reperfusion injury by attenuating endoplasmic reticulum stress-induced apoptosis through PI3K-Akt pathway. Brain Res 2011, 1367:85-93.
69. Zhang L., Yang X., Yang S., Zhang J. The Wnt /beta-catenin signaling pathway in the adult neurogenesis. Eur J Neurosci 2011, 33:1-8.
70. Zhao H., Sapolsky R.M., Steinberg G.K. Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke. Mol Neurobiol 2006, 34:249-270.